Weill Cornell GI Oncology Program

Weill Cornell GI Oncology Program Enabling patients across the entire spectrum of cancers of the digestive system to have the highest

As New York’s premier healthcare network, Weill Cornell Medicine is at the forefront of scientific research and clinical trials. The Gastrointestinal (GI) Oncology Program provides access to state-of-the-art treatments, offering patients the opportunity to receive treatments not available elsewhere. Our physicians, ranging from our medical oncologists, world-class surgical oncologists, gastroenter

ologists and radiation oncologists, use the approach of precision medicine, which provides individualized cancer treatment based on specific genetic vulnerabilities of each patient’s tumor. Gastrointestinal cancers include:

• Esophagus and gastro-esophageal cancers
• Pancreatic cancers
• Stomach (Gastric) cancers
• Colon cancers
• Re**al and a**l cancers
• Liver cancers
• Neuroendocrine cancers
• Gallbladder cancers
• Cancers of the small intestine
• Sarcomas, including GIST

Our page aims to provide you with the latest information and research developments.

Address

1305 York Avenue
New York, NY
10021

Alerts

Be the first to know and let us send you an email when Weill Cornell GI Oncology Program posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Our Story

The Gastrointestinal (GI) Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian is dedicated to providing state-of-the-art personalized care across the entire spectrum of cancers of the digestive system.

Our team works relentlessly to improve the lives of people with gastrointestinal cancer. We pride ourselves on putting patients first, tailoring treatment to each individual’s unique needs in order to maximize health outcomes and minimize potential side effects of therapy.